Brief: Syndax Pharmaceuticals Inc - Eliminates Chief Medical Officer Position
20/12/2024 22:02
Dec 20 (Reuters) - Syndax Pharmaceuticals Inc SNDX.O :
* SYNDAX PHARMACEUTICALS INC - ELIMINATES CHIEF MEDICAL
OFFICER
POSITION
* SYNDAX PHARMACEUTICALS INC - CATHERINE MADIGAN TO CEASE AS
CHIEF
MEDICAL OFFICER
Source text: ID:n0000950170-24-139121
Further company coverage: SNDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syndax Pharmaceuticals
See all newsBrief: Syndax Announces Topline Results From Maxpire Phase 2 Trial Of Axatilimab In Idiopathic Pulmonary Fibrosis
Syndax says mid-stage trial of lung disease treatment fails main goal, ends development
Syndax Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Syndax Q2 revenue jumps 92% on Revuforj, Niktimvo demand
Brief: Syndax Pharmaceuticals Q2 Operating Income USD -39.995 Million